ABCL logo

AbCellera Biologics (ABCL)

Profile

Full Name

AbCellera Biologics Inc.

Ticker Symbol

ABCL

Exchange

NASDAQ

Sector

Healthcare

Industry

Biotechnology

Country

Canada

IPO

December 11, 2020

Indexes

Not included

Website

http://www.abcellera.com

Employees

596

Key Details

Price

$3.80(+1.33%)

Market cap

Last Dividend

-

TTM Dividend yield

-

Annual revenue

$28.83M(-24.17% YoY)

Annual EPS

-$0.55(-7.84% YoY)

PE ratio

-

Next earnings date

Aug 6, 2025

Next ex-dividend date

N/A

Next split date

N/A

Quick Search

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    See Full Chart & Historical Data

    Analyst ratings

    Price

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Current Price

    $3.80
    ABCL price is $3.80

    30-Day Relative Volume

    0.31
    ABCL 30-day relative volume is 0.31

    Price Performance

    Price Today change

    +1.33%
    ABCL price is up +1.33% today

    Price YTD change

    +29.69%
    ABCL price is up +29.69% since January 1st

    Price 1-year change

    +40.22%
    ABCL price is up +40.22% year-on-year

    Price 3-year change

    -64.29%
    ABCL price is down -64.29% over the past 3 years

    Price Range

    Price All-time high

    $71.91
    ABCL price is currently -94.72% below its historical high of $71.91

    Price 3-year low

    $1.89
    ABCL price is currently +100.95% above its 3-year low

    Capitalization

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Market cap

    Market cap

    $1.13B
    ABCL market capitalization is $1.13 billion

    Market cap 3-year change

    -62.6%
    ABCL market capitalization is down -62.6% over the past 3 years

    Market cap All-time high

    $15.64B
    ABCL market capitalization is currently -92.75% below its historical high of $15.64 billion

    Market cap sector rank

    77%
    ABCL market capitalization is higher than 77% of companies in Healthcare sector

    Shares Outstanding

    Shares Outstanding 1-Year Change

    +1.3%
    ABCL shares outstanding is up +1.3% year-on-year

    Shares Outstanding 3-Year Change

    +4.71%
    ABCL shares outstanding is up +4.71% over the past 3 years

    Technical Indicators

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Beta

    1.28
    ABCL beta is 1.28

    200-day SMA

    $2.72
    ABCL price is currently +39.61% above its 200-day simple moving average

    50-day SMA

    $2.63
    ABCL price is currently +44.37% above its 50-day simple moving average

    RSI

    70.61
    ABCL 14-day relative strength index is 70.61

    Volume

    0.31
    ABCL 30-day relative volume is 0.31

    ATR

    $0.27
    ABCL average true range is $0.27

    10-day Historical Volatility

    78.33%
    ABCL 10-day historical volatility is 78.33%

    Dividend

    Income Statement

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Revenue

    Revenue

    $28.83M
    ABCL annual revenue is $28.83 million

    Revenue Analysts estimate

    $26.06M
    ABCL annual revenue is currently +10.64% higher than the consensus analysts' forecast

    Revenue 1-year change

    -24.17%
    ABCL annual revenue is down -24.17% year-on-year

    Revenue Sector rank

    38.42%
    ABCL annual revenue is higher than 38.42% of companies in Healthcare sector

    EPS

    EPS

    -$0.55
    ABCL annual earnings per share is -$0.55

    EPS Analysts estimate

    -$0.65
    ABCL annual earnings per share is currently -14.73% lower than the consensus analysts' forecast

    EPS 1-year change

    -7.84%
    ABCL annual earnings per share is down -7.84% year-on-year

    EPS Sector rank

    66.31%
    ABCL annual earnings per share is higher than 66.31% of companies in Healthcare sector

    Profit

    Gross profit

    $28.83M
    ABCL annual gross profit is $28.83 million

    Gross margin

    -
    ABCL annual gross profit margin value is unknown

    Operating profit

    -$301.15M
    ABCL annual operating income is -$301.15 million

    Operating margin

    -1044.45%
    ABCL annual operating profit margin is -1044.45%

    Net income

    -$162.86M
    ABCL annual net profit is -$162.86 million

    Net margin

    -564.83%
    ABCL annual net profit margin is -564.83%

    Expenses

    Total expenses

    $329.98M
    ABCL annual total expenses is $329.98 million

    Operating expenses

    $329.98M
    ABCL annual total operating expenses is $329.98 million

    Cost of goods sold

    -
    ABCL annual cost of goods sold value is unknown

    Selling, general & administrative expenses

    $85.49M
    ABCL annual SGA is $85.49 million

    Depreciation and amortization

    $97.00M
    ABCL annual depreciation & amortization is $97.00 million

    Interest expense

    -
    ABCL annual interest expense value is unknown

    Income tax

    -$37.54M
    ABCL annual income tax is -$37.54 million

    EBIT & EBITDA

    EBIT

    -$301.15M
    ABCL annual earnings before interest & taxes is -$301.15 million

    EBITDA

    -$204.15M
    ABCL annual EBITDA is -$204.15 million

    Balance Sheet

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Assets

    Total assets

    $1.36B
    ABCL annual total assets is $1.36 billion

    Non current assets

    $609.18M
    ABCL annual long term assets is $609.18 million

    Current assets

    $751.37M
    ABCL annual total current assets is $751.37 million

    Cash and cash equivalents

    $156.32M
    ABCL annual cash & cash equivalents is $156.32 million

    Accounts receivable

    $33.62M
    ABCL annual accounts receivable is $33.62 million

    Inventory

    -
    ABCL annual inventory value is unknown

    Liabilities

    Total liabilities

    $304.47M
    ABCL annual total liabilities is $304.47 million

    Long term liabilities

    $227.86M
    ABCL annual total long term liabilities is $227.86 million

    Current liabilities

    $76.61M
    ABCL annual total current liabilities is $76.61 million

    Accounts payable

    $34.35M
    ABCL annual accounts payable is $34.35 million

    Debt

    Total debt

    $65.36M
    ABCL annual total debt is $65.36 million

    Total debt 1-year change

    -15.53%
    ABCL annual total debt is down -15.53% year-on-year

    Long term debt

    $60.74M
    ABCL annual long term debt is $60.74 million

    Short term debt

    $4.62M
    ABCL annual short term debt is $4.62 million

    Equity & Capital

    Shareholders equity

    $1.06B
    ABCL annual stockholders equity is $1.06 billion

    Book value

    $1.06B
    ABCL annual book value is $1.06 billion

    Retained earnings

    $116.93M
    ABCL annual retained earnings is $116.93 million

    Working capital

    $674.76M
    ABCL annual working capital is $674.76 million

    Cash Flow Statement

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Cashflow Activities

    Cash from operations

    -$108.56M
    ABCL annual cash flow from operations is -$108.56 million

    Cash from operations 1-year change

    -147.41%
    ABCL annual cash flow from operations is down -147.41% year-on-year

    Cash from investing

    $121.41M
    ABCL annual cash flow from investing activities is $121.41 million

    Cash from investing 1-year change

    +154.91%
    ABCL annual cash flow from investing activities is up +154.91% year-on-year

    Cash from financing

    $12.77M
    ABCL annual cash flow from financing activities is $12.77 million

    Cash from financing 1-year change

    +23.3%
    ABCL annual cash flow from financing activities is up +23.3% year-on-year

    CAPEX

    CAPEX

    $78.40M
    ABCL annual capital expenditures is $78.40 million

    CAPEX 1-year change

    +1.15%
    ABCL annual capital expenditures is up +1.15% year-on-year

    Free Cash Flow

    Free cash flow

    -$186.95M
    ABCL annual free cash flow is -$186.95 million

    Free cash flow 1-year change

    -54.02%
    ABCL annual free cash flow is down -54.02% year-on-year

    Profitability Ratios

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Margins

    Gross margin

    -
    ABCL annual gross profit margin value is unknown

    Operating margin

    -1044.45%
    ABCL annual operating profit margin is -1044.45%

    Net margin

    -564.83%
    ABCL annual net profit margin is -564.83%

    ROA & ROE

    ROA

    -11.43%
    ABCL annual return on assets is -11.43%

    ROE

    -14.75%
    ABCL annual return on equity is -14.75%

    Valuation

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    PE Ratio

    PE ratio

    -
    ABCL price to earnings ratio value is unknown

    PE ratio Sector rank

    -
    ABCL price to earnings ratio is unknown

    PB Ratio

    PB ratio

    1.11
    ABCL price to book ratio is 1.11

    PB ratio Sector rank

    42.18%
    ABCL price to book ratio is higher than 42.18% of companies in Healthcare sector

    PS Ratio

    PS ratio

    49.07
    ABCL price to sales ratio is 49.07

    PS ratio Sector rank

    91.27%
    ABCL price to sales ratio is higher than 91.27% of companies in Healthcare sector

    Enterprise value

    Enterprise value

    $1.04B
    ABCL enterprise value is $1.04 billion

    Enterprise value Sector rank

    75.17%
    ABCL enterprise value is higher than 75.17% of companies in Healthcare sector

    EV/EBITDA

    EV/EBITDA

    -4.94
    ABCL EV/EBITDA is -4.94

    EV/EBITDA Sector rank

    23.34%
    ABCL EV/EBITDA is higher than 23.34% of companies in Healthcare sector

    Financial Health

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Liquidity

    Current ratio

    9.81
    ABCL annual current ratio is 9.81

    Quick ratio

    -
    ABCL annual quick ratio value is unknown

    Leverage

    Debt to equity

    0.00
    ABCL annual debt to equity ratio is 0.00

    Interest coverage ratio

    -
    ABCL annual interest coverage ratio value is unknown

    Risk & Stability

    Piotroski F-Score

    -
    ABCL piotroski f-score value is unknown

    Altman Z-Score

    2.24
    ABCL altman z-score is 2.24

    Analyst ratings

    Recent major analysts updates

    May 16, 25 Truist Securities
    Buy
    Apr 16, 25 Keybanc
    Overweight
    Mar 3, 25 Benchmark
    Hold
    Feb 28, 25 Stifel
    Buy
    Jan 8, 25 Keybanc
    Overweight
    Nov 5, 24 Stifel
    Buy
    Nov 5, 24 Benchmark
    Hold
    Aug 20, 24 Benchmark
    Hold
    Jul 11, 24 Keybanc
    Overweight
    May 8, 24 Keybanc
    Overweight

    Institutional Ownership

    Screeners with ABCL included

    Growing Shares Outstanding
    Stocks with high beta
    Best performing stocks last month
    Most recommended stocks
    Best performing stocks last 3 months
    NASDAQ Dividend Calendar
    Canadian stocks
    Stocks above SMA 50
    Stocks below analysts price target
    Healthcare sector
    • What is the ticker symbol for AbCellera Biologics?
    • Does AbCellera Biologics pay dividends?
    • What sector is AbCellera Biologics in?
    • What industry is AbCellera Biologics in?
    • What country is AbCellera Biologics based in?
    • When did AbCellera Biologics go public?
    • Is AbCellera Biologics in the S&P 500?
    • Is AbCellera Biologics in the NASDAQ 100?
    • Is AbCellera Biologics in the Dow Jones?
    • When was AbCellera Biologics's last earnings report?
    • When does AbCellera Biologics report earnings?
    • Should I buy AbCellera Biologics stock now?

    What is the ticker symbol for AbCellera Biologics?

    The ticker symbol for AbCellera Biologics is NASDAQ:ABCL

    Does AbCellera Biologics pay dividends?

    No, AbCellera Biologics does not pay dividends

    What sector is AbCellera Biologics in?

    AbCellera Biologics is in the Healthcare sector

    What industry is AbCellera Biologics in?

    AbCellera Biologics is in the Biotechnology industry

    What country is AbCellera Biologics based in?

    AbCellera Biologics is headquartered in Canada

    When did AbCellera Biologics go public?

    AbCellera Biologics's initial public offering (IPO) was on December 11, 2020

    Is AbCellera Biologics in the S&P 500?

    No, AbCellera Biologics is not included in the S&P 500 index

    Is AbCellera Biologics in the NASDAQ 100?

    No, AbCellera Biologics is not included in the NASDAQ 100 index

    Is AbCellera Biologics in the Dow Jones?

    No, AbCellera Biologics is not included in the Dow Jones index

    When was AbCellera Biologics's last earnings report?

    AbCellera Biologics's most recent earnings report was on May 8, 2025

    When does AbCellera Biologics report earnings?

    The next expected earnings date for AbCellera Biologics is Aug 6, 2025

    Should I buy AbCellera Biologics stock now?

    As of today, analysts generally recommend a 'Strong buy' rating. However, it's important to do your own research and consider your financial situation before making any investment decisions
    On this page